Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
LG Chem
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Subjects or the subject's legally acceptable representatives who sign a written informed consent form prior to the initiation of any study procedures.
2. Subjects with hyperuricemia and a history or presence of gout per American College of Rheumatology (ACR) criteria.
You may not be if
1. Subjects with secondary hyperuricemia (e.g., due to myeloproliferative disorder, or organ transplant).
2. Subjects experiencing an active acute gout attack within 3 weeks prior to screening (Visit 1).
Clareo Health | A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia
